Device Trial Radar · NCT07491952
Continuous Dual Aspiration Technique With Zoom System for Stroke
Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
750
Planned (sponsor's estimate)
Start
Mar 24, 2026
Primary completion
Mar 31, 2030
Study completion Jun 1, 2030
Sponsor
- Lead sponsor
- Imperative Care, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 25, 2026
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to evaluate the effectiveness, safety and clinical performance of ADAPT 2.0, first-line aspiration neurothrombectomy with Zoom System with Continuous Dual Aspiration Technique (CDAT).
Conditions
- Ischemic Stroke
- Acute Stroke
Interventions
Zoom SystemDevice
Aspiration neurothrombectomy using Zoom System with Continuous Dual Aspiration Technique (CDAT)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of patients achieving modified Thrombolysis in Cerebral Infarction (mTICI) score of ≥2c at the end of procedure, as adjudicated by independent core-labTime frame: End of procedure
- Rate of Embolization to New Territory (ENT) on final angiography at the end of the procedure by investigator assessmentTime frame: End of procedure
Locations
26 sites in 1 country. Site status is shown where the registry gives one.
Huntsville Hospital
Huntsville, Alabama · Recruiting
John Muir Health
Walnut Creek, California · Recruiting
University of South Florida
Tampa, Florida · Recruiting
23 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.